StockData
BioCardia, Inc. logo

BioCardia, Inc. (BCDA) income statement

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.77−0.02 (-2.06%)

Close on Nov 18, 2026Market cap $11.69MP/E –Yield –

See a number that looks wrong?